LRRK2 and Parkinson disease: Variants that result in increased activity of LRRK2 have been shown to be associated with an elevated risk of developing both PD and CD, whilst a haplotype with a deactivating LRRK2 mutation, R1398H, has been found to be associated with protection against CD [5] and PD [10–12].